Investigating a new cancer treatment using AZA-TDC capsules.

AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL

NIH-funded research Irisys, INC. · NIH-10710313

This study is testing a new cancer treatment called AZA-TDC capsules to see how well it works and how safe it is for patients, and it's looking for people to help find out if this new option is better than what’s already available.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIrisys, INC. NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-10710313 on NIH RePORTER

What this research studies

This research focuses on the development and clinical trial of AZA-TDC capsules, a new medication aimed at treating cancer. The capsules contain a 4 mg strength formulation that is currently not available on the market. Patients participating in this trial will receive the medication to evaluate its effectiveness and safety in combating malignant neoplasms. The study aims to gather data on how well this new treatment works compared to existing therapies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with cancer who are seeking new treatment alternatives.

Not a fit: Patients who are not diagnosed with cancer or those who have already exhausted all treatment options may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a new treatment option for patients with cancer.

How similar studies have performed: Other research has shown promise in developing new cancer therapies, but the specific approach of AZA-TDC capsules is novel.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions cancer therapyCancer Treatmentanti-cancer therapyanticancer therapycancer-directed therapy
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.